In recent years, other dual or triple receptor agonists have been developed by the pharmaceutical industry besides tirzepatide (64)
172,173 A is a typical trigger for microglial activation
Pal et al
The study was conducted with fifteen women with an average age of 42 who applied the nanoemulsion twice a day for four weeks
Bilateral injections of AAV vectors encoding for stimulatory (AAV8-hSyn-DIO-hM3Dq-mCherry, Addgene, 44361-AAV8) or inhibitory (AAV8-hSyn-dF-HA-KORD-IRES-mCitrine, Addgene, 65417-AAV8) Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) were then performed in the OB (A/P: +4.8 mm from bregma, M/L: 1 mm and D/V: 1.7 mm from brain surface) at a rate of 0.125 L/min for 4 min, on Glp1r -Cre RD and WD mice
About 68 percent of participants said their HS improved, with 62 percent experiencing fewer flares and 67 percent seeing fewer new HS lesions form while on GLP-1s